True Leaf Launches Innovative Cannabis-Based Pet Wellness Solutions

Cannabis is taking the pet care world by storm, and True Leaf aims to position itself at the helm.

This plant-forward brand has long led the way in pushing cannabinoid medicine to the forefront of the wellness industry. True Leaf’s two main operating divisions, True Leaf Medicine Inc. and True Leaf Pet Inc., now offer in-house integrative care and cannabis cultivation to serve hemp-based products to both animal and human patients around the world. The latest advocate to join their professional ranks is renowned veterinarian and Medical Director at the VCA-Canada Vancouver Animal Wellness Hospital, Dr. Katherine Kramer.

Dr. Katherine Kramer joins True Leaf Medicine Inc.

Dr. Kramer is also a longstanding pioneer for the cannabis for pets movement. She has been a vocal advocate for the research and therapeutic use of cannabis for animals since early on in her career, first inspired by the many success stories she witnessed to blend herbs and acupuncture with Western veterinary medicine as a more integrated and natural approach to care.

Dr. Kramer joins True Leaf to lead the development of the company’s new medicinal cannabis product line for pets, lending her expert knowledge and experience on the safe use, dosage, and efficacy of administering medicinal cannabis to animals. This line will of cannabidiol (CBD) products is anticipated to be launched to the veterinary market in 2019 alongside educational programs . Dr. Kramer’s work with the Canadian Association of Veterinary Cannabinoid Medicine (CAVCM) also aims to amend Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) to permit the future classification of CBD as a Veterinary Health Product, which would open the door for True Leaf to bring legal, safe, and quality-controlled CBD products to market for Canadian pets.